These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 3391527)

  • 21. The effects of colestipol on the metabolism of very-low-density lipoproteins in man.
    Witztum JL; Schonfeld G; Weidman SW
    J Lab Clin Med; 1976 Dec; 88(6):1008-18. PubMed ID: 186544
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Results of colestipol therapy in Type II hyperlipoproteinemia.
    Lees AM; McCluskey MA; Lees RS
    Atherosclerosis; 1976; 24(1-2):129-40. PubMed ID: 182181
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of colestipol and clofibrate on plasma lipid and lipoproteins in type IIa hyperlipoproteinemia.
    Hunninghake DB; Probstfield JL; Crow LO; Isaacson SO
    Metabolism; 1981 Jun; 30(6):605-9. PubMed ID: 7231197
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Colestipol, clofibrate, and phytosterols in combined therapy of hyperlipidemia.
    Grundy SM; Mok HY
    J Lab Clin Med; 1977 Feb; 89(2):354-66. PubMed ID: 833472
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Therapy of hyperlipidemic states.
    Havel RJ; Kane JP
    Annu Rev Med; 1982; 33():417-33. PubMed ID: 7044276
    [No Abstract]   [Full Text] [Related]  

  • 26. Hypercholesterolemia and hypertriglyceridemia in children. A pediatric approach to primary atherosclerosis prevention.
    Glueck CJ; Fallat RW; Tsang R
    Am J Dis Child; 1974 Oct; 128(4):569-77. PubMed ID: 4370078
    [No Abstract]   [Full Text] [Related]  

  • 27. The effect of colestipol or cholestyramine on serum cholesterol and triglycerides in a long-term controlled study.
    Ryan JR; Jain A
    J Clin Pharmacol New Drugs; 1972 Jul; 12(7):268-73. PubMed ID: 4557535
    [No Abstract]   [Full Text] [Related]  

  • 28. Anion-exchange resins in antibiotic-associated colitis.
    Chang TW; Onderdonk AB; Bartlett JG
    Lancet; 1978 Jul; 2(8083):258-9. PubMed ID: 79047
    [No Abstract]   [Full Text] [Related]  

  • 29. The effects of cholestyramine, colestipol, and ADR-132 on the rat prostate and dunning R-3327 adenocarcinoma.
    Brown WJ; Karr JP; McGarry M; Williams PD; Hagerman LM; Murphy GP
    J Surg Oncol; 1983 Apr; 22(4):273-7. PubMed ID: 6834849
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of cholestyramine on lipoprotein lipids in patients with primary type IIA hyperlipoproteinemia.
    Weisweiler P; Neureuther G; Schwandt P
    Atherosclerosis; 1979 Jul; 33(3):295-300. PubMed ID: 226105
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Treatment of familial hypercholesterolemia - hyperlipoproteinemia type II with anion exchange resins].
    Kusić M; Gavrilović M; Mihajlović M; Bosković B
    Vojnosanit Pregl; 1981; 38(1):23-7. PubMed ID: 7245659
    [No Abstract]   [Full Text] [Related]  

  • 32. [Lipid-lowering drugs. Therapeutics and adverse effects].
    Vogelberg KH
    Med Klin; 1979 Aug; 74(32-33):1171-8. PubMed ID: 224293
    [No Abstract]   [Full Text] [Related]  

  • 33. Diet, drugs, and plasma exchange in the treatment of hyperlipidemia in childhood.
    Mancini M; Postiglione A; Farinaro E; Montefusco S
    Prev Med; 1983 Nov; 12(6):848-53. PubMed ID: 6676732
    [No Abstract]   [Full Text] [Related]  

  • 34. Dietary and drug treatment of primary hyperlipoproteinemia.
    Ann Intern Med; 1972 Aug; 77(2):267-94. PubMed ID: 4345081
    [No Abstract]   [Full Text] [Related]  

  • 35. Hypercholesterolemia: new values, new strategies.
    Lueg MC; Anding RH
    Hosp Pract (Off Ed); 1986 Jan; 21(1A):112-3, 116-7, 120-2. PubMed ID: 3080456
    [No Abstract]   [Full Text] [Related]  

  • 36. The detection and management of dyslipidaemia in children and adolescents.
    Ose L; Tonstad S
    Acta Paediatr; 1995 Nov; 84(11):1213-5. PubMed ID: 8580613
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of combined diet and colestipol in long-term (7--7 1/2 years) treatment of patients with type II hyperlipoproteinemia.
    Kuo PT; Hayase K; Kostis JB; Moreyra AE
    Circulation; 1979 Feb; 59(2):199-211. PubMed ID: 215338
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anion-exchange resins in pseudomembranous colitis.
    George RH; Youngs DJ; Johnson EM; Burdon DW
    Lancet; 1978 Sep; 2(8090):624. PubMed ID: 80541
    [No Abstract]   [Full Text] [Related]  

  • 39. Treatment of hypercholesterolaemia with colestipol: a bile sequestrating agent.
    Nye ER; Jackson D; Hunter JD
    N Z Med J; 1972 Jul; 76(482):12-6. PubMed ID: 4344110
    [No Abstract]   [Full Text] [Related]  

  • 40. Response of hyperlipoproteinemia to colestipol.
    Sachs BA; Wolfman L
    N Y State J Med; 1973 May; 73(9):1068-70. PubMed ID: 4512165
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.